In our study individuals with the GSTT1 null or with both the GSTT1 null and GSTM1 null genotypes showed a higher risk of MM compared to patients carrying non-deleted GSTT1/GSTM1 genotypes. This evidence concerns the gene GSTM1 and Miyoshi myopathy.